A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

Addiction

Volumn 110, Issue 4, 2015, Pages 646-655

  Burns, Lucy ^a   Gisev, Natasa ^a   Larney, Sarah ^a,b   Dobbins, Timothy ^c   Gibson, Amy ^d   Kimber, Jo ^a   Larance, Briony ^a   Mattick, Richard P ^a   Butler, Tony ^e,f   Degenhardt, Louisa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BROWN UNIVERSITY   (United States)

^c The Australian National University   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Buprenorphine; Methadone; Opioid dependence; Opioid substitution treatment; Treatment retention

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; COMPARATIVE STUDY; CRIME; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW SOUTH WALES; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DROPOUT; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; CRIME; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; METHADONE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW SOUTH WALES; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84924678494     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12834     Document Type: Article

References (11)

1. Ward J., Mattick R. P., Hall W. Methadone Maintenance Treatment and Other Opioid Replacement Pharmacotherapies. Amsterdam: Harwood Academic Publishers; 1998.
2. Mattick R. P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003; 2: 1-32, CD002209.
3. Ward J., Hall W., Mattick R. Methadone maintenance treatment. In: Mattick R. P., Ali R., Lintzeris N. editors. Pharmacotherapies for the Treatment of Opioid Dependence. New York: Informa Healthcare; 2009; 107-41.
4. Mattick R. P., Breen C., Kimber J., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014; 2: 1-61, CD002207.
5. Mattick R. P., Ali R., White J. M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003; 984: 441-52.
6. Burns L., Randall D., Hall W. D., Law M., Butler T., Bell J. et al. Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction 2009; 1048: 1363-72.
7. Larance B., Degenhardt L., Lintzeris N., Bell J., Winstock A., Dietze P. et al. Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing. Drug Alcohol Depend 2011; 1182: 265-73.
8. Larance B., Degenhardt L., Lintzeris N., Winstock A., Mattick R. Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev 2011; 303: 236-45.
9. Pink B. Australian and New Zealand Standard Offence Classification (ANZSOC), 3rd edn. Canberra, Australia: Australian Bureau of Statistics; 2011.
10. Goh D., Holmes J. New South Wales recorded crime statistics. NSW Bureau of Crime Statistics and Research. Sydney: Department of Attorney General and Justice; 2014.
11. Drug and Alcohol Office. A retrospective observational study of two types of pharmacotherapy treatment for opiate dependence in Western Australia. Drug and Alcohol Office Research Report. Drug and Alcohol Office: Perth, Western Australia; 2014.